These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3928064)

  • 1. Chlorthalidone treatment in patients with hypertension associated with hypokalaemia.
    Skerrett FD
    Br Med J (Clin Res Ed); 1985 Sep; 291(6496):642. PubMed ID: 3928064
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal dose of a thiazide diuretic.
    Carney S; Gillies AI; Morgan T
    Med J Aust; 1976 Oct; 2(18):692-3. PubMed ID: 796642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of chlorothiazide, chlorthalidone and cyclopenthiazide in the treatment of hypertension.
    Louis WJ; Doyle AE; Dawborn JK; Johnston CI
    Med J Aust; 1973 Jul; 2(1):23-5. PubMed ID: 4725465
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
    Carpentiere G; Marino S; Castello F
    Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the effects and side effects of a diuretic].
    Holtmeier HJ; Steim H; Danner H; Marongiu F
    Med Welt; 1967 Jun; 22():1384-94. PubMed ID: 5611507
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R; Struyvenberg A
    Eur J Clin Invest; 1978 Jun; 8(3):155-64. PubMed ID: 28952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium loss associated with hydrochlorothiazide versus chlorthalidone.
    Sumiye L; Vivian AS; Frisof KB; Podany EC
    Clin Ther; 1981; 4(4):308-20. PubMed ID: 7332917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study.
    Dhalla IA; Gomes T; Yao Z; Nagge J; Persaud N; Hellings C; Mamdani MM; Juurlink DN
    Ann Intern Med; 2013 Mar; 158(6):447-55. PubMed ID: 23552325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of arrythmia during severe chlorthalidone induced hypokalaemia.
    Collart F; Laurent M; Ducobu J
    Acta Clin Belg; 1982; 37(5):320. PubMed ID: 7158222
    [No Abstract]   [Full Text] [Related]  

  • 11. The antihypertensive and biochemical effects of hydrochlorothiazide/amiloride (Moduretic) versus chlorthalidone.
    van Soeren F
    J Int Med Res; 1980; 8(2):132-5. PubMed ID: 6989682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrochlorothiazide versus chlorthalidone in the management of hypertension.
    Neff KM; Nawarskas JJ
    Cardiol Rev; 2010; 18(1):51-6. PubMed ID: 20010338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism underlying chlorthalidone-induced hypokalaemia: effects of sodium restriction, potassium suppletion, spironolactone, and triamterene.
    Haalboom JR; Struyvenberg A
    Neth J Med; 1982; 25(7):184-92. PubMed ID: 7144988
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of diuretics in treatment of hypertension in the elderly.
    Smith WM; Feigal DW; Furberg CD; Greenlick M; Kuller L; Perry HM; Schnaper HW; Schoenberger JA
    Drugs; 1986; 31 Suppl 4():154-64. PubMed ID: 3732093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chlorthalidone at low doses in the treatment of mild and moderate hypertension: analysis of efficacy, hypokalemia frequency and cardiac rhythm disorders].
    Plavnik FL; Ribeiro AB; Maranhão MF; Nusbaum IM; Kohlmann Júnior O
    Arq Bras Cardiol; 1988 Feb; 50(2):135-8. PubMed ID: 3063238
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypokalemic rhabdomyolysis associated with diuretic and beta blockader therapy].
    Acquarone N; Vinciguerra G; Crisalli MP
    Recenti Prog Med; 1987 Jan; 78(1):33-5. PubMed ID: 3589118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aldosteronism after hypokalemia in diuretic therapy of systemic arterial hypertension].
    Sánchez Torres G; Posadas C; Olvera S; Serrano P
    Arch Inst Cardiol Mex; 1978; 48(4):853-70. PubMed ID: 697472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic-induced hypokalemia and altered renal function.
    Carney SL; Morgan TO
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):665-7. PubMed ID: 3546168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension.
    Bachmann H
    Helv Paediatr Acta; 1984 Mar; 39(1):55-61. PubMed ID: 6373679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting and short-acting diuretics in the treatment of hypertension.
    Pupita F; Belogi M; Ansuini R; Campolucci G
    Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.